DoD takes lead on finding drugs to fight superbugs
http://www.navytimes.com/article/20140831/NEWS/308310021/DoD-takes-lead-finding-drugs-fight-superbugs
DoD takes lead on finding drugs to fight superbugs
Aug. 31, 2014 - 06:00AM |
By Patricia Kime
Staff writer
With very few antibiotics in development at major pharmaceutical companies, the Pentagon is stepping in to support research to combat the growing threat of superbugs bacteria that cant be stopped with current medications.
(snip)
The threat to readiness and emerging issues worldwide with drug-resistant microbes are leading DoD to spend more than $40 million a year to support research and development of vaccines or medications to treat the germs.
(snip)
Lesho said Big Pharma has no incentives to study and pursue this issue because it lacks the potential to create high profit margins.
One recent research initiative jump-started with Pentagon funding is a vaccine for the norovirus, the hard-to-kill germ that afflicts cruise ships and can send entire units running to the latrines.
(snip)
The Presidents Council of Advisors on Science and Technology is set to publish a report that likely will create a task force on antibiotic resistance and call for germ genome sequencing as well as incentives for drug firms to invest in research.
(snip)
The Pentagon also is taking a close look at anti-fungal treatments. In 2010, the rate of fungal infections in trauma cases among U.S. troops reached 3.5 percent.
(snip)
The Trauma and Infectious Disease Outcomes Study, underway at the Uniformed Services University of the Health Sciences, is following service members who were injured or sickened during the recent wars.
(snip)